西妥昔单抗会影响副肿瘤性肌病吗？
Can cetuximab affect paraneoplastic myopathy?
作者信息
Galani Eleni, Bonakis Anastasios, Christodoulou Christos, Klouvas George, Drougou Angeliki, Skarlos Dimostenis
机构信息
Second Oncology Department, Metropolitan Hospital, Athens, Greece.
出版信息
J Neurooncol. 2009 Jul;93(3):437-8. doi: 10.1007/s11060-009-9795-6. Epub 2009 Jan 22.
PMID:19159079
Abstract
Cetuximab given concurrently with chemotherapy has shown survival benefit for patients with metastatic colon cancer. We report a case of a patient with metastatic colon cancer who developed paraneoplastic necrotizing myopathy that possibly responded to cetuximab despite lack of improvement of the underlying cancer.
摘要
西妥昔单抗与化疗同时使用已显示出对转移性结肠癌患者有生存益处。我们报告了一例转移性结肠癌患者，该患者发生了副肿瘤性坏死性肌病，尽管基础癌症未改善，但该患者可能对西妥昔单抗有反应。
Zotero 插件